Edition:
United Kingdom

People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

114.29USD
18 Apr 2019
Change (% chg)

$2.91 (+2.61%)
Prev Close
$111.38
Open
$111.86
Day's High
$114.81
Day's Low
$107.44
Volume
517,620
Avg. Vol
450,045
52-wk High
$156.16
52-wk Low
$72.04

Sayer, Kevin 

Mr. Kevin R. Sayer serves as Chairman of the Board, President, Chief Executive Officer of DexCom Inc. He has served on our Board since November 2007 and as our President since June 2011. From January 2013 until January 2015, Mr. Sayer also served as our Chief Operating Officer. In connection with Mr. Gregg assuming a new role as Executive Chairman of the Board of Directors, Mr. Sayer assumed the role of Chief Executive Officer effective on January 1, 2015. From April 2007 to December 2010, Mr. Sayer served as Chief Financial Officer of Biosensors International Group, Ltd. (“Biosensors”), a medical technology company developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures. Prior to joining Biosensors, from May 2005 to April 2007, Mr. Sayer served as an independent healthcare and medical technology industry consultant. From March 2004 to May 2005, Mr. Sayer was Executive Vice President and Chief Financial Officer of Specialty Laboratories, Inc., a company offering clinical reference laboratory services. From August 2002 to March 2004, Mr. Sayer worked as an independent healthcare and medical technology industry consultant. Mr. Sayer served as Chief Financial Officer of MiniMed, Inc. from May 1994 until it was acquired by Medtronic, Inc. in August 2001. Mr. Sayer served as Vice President and General Manager of Medtronic MiniMed after the acquisition until August 2002. Mr. Sayer is a Certified Public Accountant (inactive) and received his Master’s Degree in Accounting and Information Systems concurrently with a B.A., both from Brigham Young University.

Basic Compensation

Total Annual Compensation, USD 1,543,160
Restricted Stock Award, USD 6,359,270
Long-Term Incentive Plans, USD --
All Other, USD 22,446
Fiscal Year Total, USD 7,924,870

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Sayer

7,924,870

Quentin Blackford

5,115,200

Donald Abbey

2,919,160

Andrew Balo

3,016,910

Richard Doubleday

2,919,160

Steven Pacelli

2,919,160
As Of  31 Dec 2017